What regulation governs the requirements for patent applications with nucleotide and/or amino acid sequence disclosures?
The requirements for patent applications with nucleotide and/or amino acid sequence disclosures are governed by 37 CFR 1.831. This is referenced in MPEP 2412.03(c): 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures. This regulation sets forth the specific requirements that patent applicants…
Read More